July 28, 2021
July 28, 2021 – The U.S. FDA has approved two new indications for Merck’s Keytruda (pembrolizumab),
one for endometrial carcinoma and one for triple negative breast cancer (TNBC)
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
July 27, 2021
July 27, 2021 – The U.S. FDA has approved Twyneo® (tretinoin/benzoyl peroxide) cream, manufactured by Sol-Gel Technologies
July 26, 2021
July 26, 2021 – GlaxoSmithKline's Shingrix® (zoster vaccine recombinant, adjuvanted) has received U.S. FDA approval for an expanded indication
July 23, 2021
July 23, 2021
July 23, 2021 – The U.S. FDA has approved an expanded indication for Bydureon BCise (exenatide extended release), manufactured by AstraZeneca. Initially FDA approved
July 23, 2021
July 23, 2021 – Bristol Myers Squibb has voluntarily withdrawn an indication for Opdivo® (nivolumab) to be used as a single agent to treat patients who have hepatocellular
July 23, 2021
July 23, 2021 – The U.S. FDA has approved a new indication for Drizalma SprinkleTM (duloxetine) delayed-release oral capsules, manufactured by Sun Pharmaceutical. The capsules are
July 20, 2021
July 20, 2021 – Pfizer has recalled multiple lots of Chantix® (varenicline) and paused global distribution
after testing identified N-nitroso-